Afinitor

Generic name: everolimus

Used for: HR-positive, HER2-negative breast cancer after menopause · Neuroendocrine tumors of the pancreas, digestive tract or lung · Advanced kidney cancer (renal cell carcinoma) · Kidney tumors in tuberous sclerosis complex (angiomyolipoma) · Brain tumor in tuberous sclerosis complex (SEGA) · 4 more

How do you pay?

How to pay the least

From

$193.84 for 30 tablets delivered ($188.59 plus $5.25 shipping)

Generic everolimus from Cost Plus Drugs, by mail. Pick the strength on your label above for its own price.

  1. Make a free account on costplusdrugs.com. Ask your prescriber to send the prescription there, or Cost Plus Drugs can transfer it.Open Cost Plus Drugs 
  2. Order generic everolimus. It comes by mail.

Need it today? From $222.95 for 30 tablets with the free Team Cuban Card, at pharmacies that take it. Get the free card and show it there.

See the price and get the card 

A regular generic has the same active ingredient as Afinitor, and the FDA requires it to work the same way.

Compare every option

Question
Brand nameAfinitor
Authorized genericeverolimus
Regular genericeverolimus
What you’d pay
Cash priceAsk the pharmacyUsually the highest price
Not soldThere isn’t one
From$193.84for 30 tablets at Cost Plus Drugs, with shipping
Same as Afinitor?
The original
–
Same active ingredientFillers and dyes can differ

Brand nameThe maker’s card

Novartis Oncology Universal Co-pay Program

Savings card from Novartis

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

The card takes up to $15,000 a year off your co-pay.

Sign up on afinitor-hcp.com 

Or call 1-800-282-7630.

In the maker’s words

“Eligible patients with private insurance may pay $0 per month…”

From the maker’s offer on afinitor-hcp.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Afinitor itself, from the same company, sold without the brand name, and usually for less. A regular generic is sold, with the same active ingredient: ask the pharmacy for its price.

See the regular generic →

Regular genericWhere to buy it

Pharmacies’ own cash prices for generic everolimus, lowest first.

Pick up in storeDelivered

From each pharmacy’s own site, read November 2, 2026. Confirm the price before you fill.

About these prices

Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.

Regular genericMakers and their savings cards

7 companies sell a generic of Afinitor that the FDA rates a substitute. A pharmacy fills whichever one it stocks. 2 of them have their own savings cards or programs, listed first. Each works only with that maker’s version. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.

  • Breckenridge PharmaceuticalAll 4 strengths

    Has lactose

    Everolimus Tablets for Oral Suspension (Everolimus TFOS) Savings Program

    With commercial insurance as little as $0

    Sign up on everolimustabletsfororalsuspension.copaysavingsprogram.com

    Or call 1-877-340-2833.

    In the maker’s words

    “Under the program, qualifying patients may pay as little as $0 out of pocket per prescription.”

    Product page on breckenridgepharma.com

    How it looks, what’s in it, NDCs

    2.5 mg White, oval, 10 mm, marked “EVR / 2 / 5”

    PackageNDC
    Carton of 2851991-821-28
    Bottle of 3051991-821-33

    5 mg White, oval, 12 mm, marked “EVR / 5”

    PackageNDC
    Carton of 2851991-822-28
    Bottle of 3051991-822-33

    7.5 mg White, oval, 14 mm, marked “EVR / 7 / 5”

    PackageNDC
    Carton of 2851991-823-28
    Bottle of 3051991-823-33

    10 mg White, oval, 15 mm, marked “EVR / NAT”

    PackageNDC
    Carton of 2851991-824-28
    Bottle of 3051991-824-33

    Inactive ingredients: acetone, anhydrous lactose, butylated hydroxytoluene, hypromellose 2910 (3 mpa.s), crospovidone (120 .mu.m), magnesium stearate

    FDA label

  • CivicaScriptAll 4 strengths

    Has lactose · Sold as Yulithira · Made by Breckenridge Pharmaceutical

    MaxRP (maximum recommended price to the consumer)

    “CivicaScript’s MaxRP® policy is our maximum recommended price to the consumer.” (anyone)

    See the program

    How it looks, what’s in it, NDCs

    2.5 mg White, oval, 10 mm, marked “EVR / 2 / 5”

    PackageNDC
    Bottle of 3082249-610-30

    5 mg White, oval, 12 mm, marked “EVR / 5”

    PackageNDC
    Bottle of 3082249-611-30

    7.5 mg White, oval, 14 mm, marked “EVR / 7 / 5”

    PackageNDC
    Bottle of 3082249-612-30

    10 mg White, oval, 15 mm, marked “EVR / NAT”

    PackageNDC
    Bottle of 3082249-613-30

    Inactive ingredients: acetone, anhydrous lactose, butylated hydroxytoluene, hypromellose 2910 (3 mpa.s), crospovidone (120 .mu.m), magnesium stearate

    FDA label

  • Biocon PharmaAll 4 strengths

    Has lactose

    How it looks, what’s in it, NDCs

    2.5 mg White to off white, capsule, 10 mm, marked “B2 / 5”

    PackageNDC
    Carton of 2870377-010-22
    Carton of 2870377-010-23
    Bottle of 3070377-010-11

    5 mg White to off white, capsule, 12 mm, marked “B5”

    PackageNDC
    Carton of 2870377-011-22
    Carton of 2870377-011-23
    Bottle of 3070377-011-11

    7.5 mg White to off white, capsule, 15 mm, marked “B7 / 5”

    PackageNDC
    Carton of 2870377-012-22
    Carton of 2870377-012-23
    Bottle of 3070377-012-11

    10 mg White to off white, capsule, 17 mm, marked “B10”

    PackageNDC
    Carton of 2870377-013-22
    Carton of 2870377-013-23
    Bottle of 3070377-013-11

    Inactive ingredients: anhydrous lactose, butylated hydroxytoluene, crospovidone, hypromellose 2208 (3 mpa.s), lactose monohydrate, magnesium stearate

    FDA label

  • Hikma PharmaceuticalsAll 4 strengths

    Has lactose

    How it looks, what’s in it, NDCs

    2.5 mg White, capsule, 10 mm, marked “54 / 391”

    PackageNDC
    Bottle of 300054-0480-13

    5 mg White, capsule, 12 mm, marked “54 / 451”

    PackageNDC
    Bottle of 300054-0481-13

    7.5 mg White, capsule, 14 mm, marked “54 / 627”

    PackageNDC
    Bottle of 300054-0497-13

    10 mg White, capsule, 15 mm, marked “54 / 701”

    PackageNDC
    Bottle of 300054-0482-13

    Inactive ingredients: butylated hydroxytoluene, crospovidone (120 .mu.m), hypromellose 2910 (5 mpa.s), anhydrous lactose, magnesium stearate

    FDA label

  • NorthStar RxAll 4 strengths

    Has lactose · Made by Biocon Pharma

    Product page on northstarrxllc.com

    How it looks, what’s in it, NDCs

    2.5 mg White to off white, capsule, 10 mm, marked “B2 / 5”

    PackageNDC
    Bottle of 3072603-254-01

    5 mg White to off white, capsule, 12 mm, marked “B5”

    PackageNDC
    Bottle of 3072603-255-01

    7.5 mg White to off white, capsule, 15 mm, marked “B7 / 5”

    PackageNDC
    Bottle of 3072603-256-01

    10 mg White to off white, capsule, 17 mm, marked “B10”

    PackageNDC
    Bottle of 3072603-257-01

    Inactive ingredients: anhydrous lactose, butylated hydroxytoluene, crospovidone, hypromellose 2208 (3 mpa.s), lactose monohydrate, magnesium stearate

    FDA label

  • Novugen PharmaAll 4 strengths

    Has lactose · Made by Neocubes Pharma LLP

    How it looks, what’s in it, NDCs

    2.5 mg White to slightly yellow, oval, 10 mm, marked “EVE / 2 / 5”

    PackageNDC
    Bottle of 2882293-030-10
    Carton of 2882293-030-21
    Carton of 3082293-030-31

    5 mg White to slightly yellow, oval, 12 mm, marked “EVE / 5”

    PackageNDC
    Bottle of 2882293-031-10
    Carton of 2882293-031-21
    Carton of 3082293-031-31

    7.5 mg White to slightly yellow, oval, 14 mm, marked “EVE / 7 / 5”

    PackageNDC
    Bottle of 2882293-032-10
    Carton of 2882293-032-21
    Carton of 3082293-032-31

    10 mg White to slightly yellow, oval, 15 mm, marked “EVE / 10”

    PackageNDC
    Bottle of 2882293-033-10
    Carton of 2882293-033-21
    Carton of 3082293-033-31

    Inactive ingredients: anhydrous lactose, butylated hydroxytoluene, crospovidone, hypromellose 2910 (3 mpa.s), magnesium stearate

    FDA label

  • Upsher-Smith LaboratoriesAll 4 strengths

    Has lactose · Sold as Torpenz · Made by Biocon Pharma

    Product page on upsher-smith.com

    How it looks, what’s in it, NDCs

    2.5 mg (White to off-white), capsule, 10 mm, marked “B / 2 / 5”

    PackageNDC
    Carton of 280245-0822-04
    Bottle of 300245-0822-30

    5 mg (White to off-white), capsule, 12 mm, marked “B / 5”

    PackageNDC
    Carton of 280245-0823-04
    Bottle of 300245-0823-30

    7.5 mg (White to off-white), capsule, 15 mm, marked “B / 7 / 5”

    PackageNDC
    Carton of 280245-0824-04
    Bottle of 300245-0824-30

    10 mg (White to off-white), capsule, 17 mm, marked “B / 10”

    PackageNDC
    Carton of 280245-0825-04
    Bottle of 300245-0825-30

    Inactive ingredients: butylated hydroxytoluene, crospovidone, hypromellose 2208 (3 mpa.s), lactose monohydrate, anhydrous lactose, magnesium stearate

    FDA label

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

What to say at the pharmacy

“Before you fill my Afinitor, can you tell me what I’d pay for the brand and for a generic?”

Paying cash? Ask for each one’s cash price. With insurance, ask what your plan charges for each.

What it’s used for

What the FDA label says

AFINITOR is a kinase inhibitor indicated for the treatment of:

  • Postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer in combination with exemestane after failure of treatment with letrozole or anastrozole.
  • Adults with progressive neuroendocrine tumors of pancreatic origin (PNET) and adults with progressive, well-differentiated, non-functional neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin that are unresectable, locally advanced or metastatic. Limitations of Use: AFINITOR is not indicated for the treatment of patients with functional carcinoid tumors.
  • Adults with advanced renal cell carcinoma (RCC) after failure of treatment with sunitinib or sorafenib.
  • Adults with renal angiomyolipoma and tuberous sclerosis complex (TSC), not requiring immediate surgery.

AFINITOR and AFINITOR DISPERZ are kinase inhibitors indicated for the treatment of adult and pediatric patients aged 1 year and older with TSC who have subependymal giant cell astrocytoma (SEGA) that requires therapeutic intervention but cannot be curatively resected.

AFINITOR DISPERZ is a kinase inhibitor indicated for the adjunctive treatment of adult and pediatric patients aged 2 years and older with TSC-associated partial-onset seizures.

Source: the FDA label for Afinitor (Novartis Pharmaceuticals Corporation), June 1, 2026. Full label on DailyMed 

Good to know

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/afinitor/